Apremilast and Ulcerative colitis - a phase IV clinical study of FDA data

Summary:

Ulcerative colitis is reported as a side effect among people who take Apremilast (apremilast), especially for people who are female, 40-49 old, also take Diclofenac Potassium, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ulcerative colitis when taking Apremilast. It is created by eHealthMe based on reports of 4,162 people who have side effects when taking Apremilast from the FDA, and is updated regularly.

What is Apremilast?

Apremilast has active ingredients of apremilast. eHealthMe is studying from 4,162 Apremilast users. Check the latest studies of Apremilast.

What is Ulcerative colitis?

Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with 1,195 drugs and 2,055 conditions by eHealthMe. Check the latest studies of Ulcerative colitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,162 people reported to have side effects when taking Apremilast.
Among them, 18 people (0.43%) have Ulcerative colitis.

Could Apremilast cause Ulcerative colitis?

Among these 18 people:

What is the gender of people who have Ulcerative colitis when taking Apremilast? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Ulcerative colitis when taking Apremilast? *

What are other drugs people take besides Apremilast? *

Acetaminophen: 16 people, 88.89%
Actemra: 16 people, 88.89%
Remicade: 16 people, 88.89%
Celebrex: 16 people, 88.89%
Simponi: 16 people, 88.89%
Cetirizine Hydrochloride: 16 people, 88.89%
Prednisone: 16 people, 88.89%
Hydrocortisone: 16 people, 88.89%
Doxycycline: 16 people, 88.89%
Diclofenac Potassium: 16 people, 88.89%

What are other side effects people have besides Ulcerative colitis? *

Oedema (fluid collection in tissue): 16 people, 88.89%
Nausea (feeling of having an urge to vomit): 16 people, 88.89%
Dizziness: 16 people, 88.89%
Breast Cancer Stage Iii: 15 people, 83.33%
Diarrhea: 15 people, 83.33%
Insomnia (sleeplessness): 14 people, 77.78%
Abdominal Pain Upper: 14 people, 77.78%
Adverse Event: 12 people, 66.67%
Urticaria (rash of round, red welts on the skin that itch intensely): 12 people, 66.67%
Drug Hypersensitivity: 12 people, 66.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 88.89%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 15 people, 83.33%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 50.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 50.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 9 people, 50.00%
Inflammation: 7 people, 38.89%
Fever: 7 people, 38.89%
Pain: 7 people, 38.89%
Synovitis (inflammation of the synovial membrane): 6 people, 33.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Apremilast and have Ulcerative colitis?

- Check whether Ulcerative colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apremilast:

Apremilast (4,162 reports)

Browse all side effects of Apremilast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ulcerative colitis:

Ulcerative colitis (1,195 drugs)

Browse all the conditions that are associated with Ulcerative colitis:

Ulcerative colitis (2,055 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apremilast (the active ingredients of Apremilast) and Apremilast (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.